Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- London
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- N/A
- Filings on record
- 999 filings
- On EDGAR
- CIK 1635088
- Fiscal year ends
- March
- Filer status
- Large accelerated filer
Financials 8 of 22
News 8 of 83
- 8-K Quarterly results Nov 9, 2026
- 8-K Current report on a material event Oct 21, 2026
- 8-K Shareholder vote results Sep 18, 2026
- 8-K Current report on a material event Sep 8, 2026
- 8-K Other events Aug 28, 2026
- 8-K Current report on a material event Aug 27, 2026
- 8-K Quarterly results Aug 6, 2026
- 8-K Quarterly results May 20, 2026
Prospectuses and Registrations 8 of 50
- S-8 Registration statement for an employee plan May 20, 2026
- S-3ASR Automatic shelf registration Oct 3, 2025
- S-8 Registration statement for an employee plan Jul 26, 2024
- 424B5 Prospectus supplement for an offering Oct 6, 2023
- S-3 Shelf registration statement Sep 29, 2023
- 424B5 Prospectus supplement for an offering Sep 26, 2023
- 25-NSE Notice that a security was delisted Sep 1, 2023
- S-8 Registration statement for an employee plan Jun 29, 2023
Proxies 8 of 10
- DEFA14A Extra proxy material Jul 29, 2026
- DEF 14A Proxy statement for a shareholder vote Jul 29, 2026
- DEF 14A Proxy statement for a shareholder vote Jul 29, 2025
- DEFA14A Extra proxy material Jul 29, 2025
- DEFA14A Extra proxy material Jul 26, 2024
- DEF 14A Proxy statement for a shareholder vote Jul 26, 2024
- DEFA14A Extra proxy material Jul 31, 2023
- DEF 14A Proxy statement for a shareholder vote Jul 31, 2023
Ownership 8 of 788
- 4 Insider reported a trade Nov 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- 144 Notice of a proposed sale of restricted stock Nov 3, 2026
- 4 Insider reported a trade Oct 30, 2026
- 144 Notice of a proposed sale of restricted stock Oct 28, 2026
- 4 Insider reported a trade Oct 27, 2026
- 4 Insider reported a trade Oct 27, 2026
- 4 Insider reported a trade Oct 27, 2026
Other 8 of 46
- ARS Annual report sent to shareholders Jul 29, 2026
- ARS Annual report sent to shareholders Jul 29, 2025
- ARS Annual report sent to shareholders Jul 26, 2024
- EFFECT Notice that a registration became effective Oct 6, 2023
- CORRESP Reply to SEC staff Oct 4, 2023
- UPLOAD Comment letter from SEC staff Oct 4, 2023
- ARS Annual report sent to shareholders Aug 7, 2023
- EFFECT Notice that a registration became effective Oct 3, 2022
Everything here comes from Roivant Sciences Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.